707 related articles for article (PubMed ID: 25523560)
1. Conventional drug therapy for inflammatory bowel disease.
Bryant RV; Brain O; Travis SP
Scand J Gastroenterol; 2015 Jan; 50(1):90-112. PubMed ID: 25523560
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
[TBL] [Abstract][Full Text] [Related]
4. General principles of medical therapy of inflammatory bowel disease.
Friedman S
Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease: current therapeutic options.
Domènech E
Digestion; 2006; 73 Suppl 1():67-76. PubMed ID: 16498254
[TBL] [Abstract][Full Text] [Related]
6. [Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].
Fiasse R; Denis MA; Dewit O
J Pharm Belg; 2010 Mar; (1):1-9. PubMed ID: 20432590
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNF therapy in inflammatory bowel diseases: a huge review.
Peyrin-Biroulet L
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):233-43. PubMed ID: 20485259
[TBL] [Abstract][Full Text] [Related]
8. Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice.
Zabana Y; Domènech E; Mañosa M; Garcia-Planella E; Bernal I; Cabré E; Gassull MA
Aliment Pharmacol Ther; 2010 Mar; 31(5):553-60. PubMed ID: 20002026
[TBL] [Abstract][Full Text] [Related]
9. Optimizing therapy for inflammatory bowel disease.
Robinson M
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
[TBL] [Abstract][Full Text] [Related]
10. [Biologic therapies in inflammatory bowel disease: anti-TNF and new therapeutic targets].
Flamant M; Bourreille A
Rev Med Interne; 2007 Dec; 28(12):852-61. PubMed ID: 17628232
[TBL] [Abstract][Full Text] [Related]
11. Advances in inflammatory bowel diseases in children.
Michail S; Ramsy M; Soliman E
Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
Sokol H; Seksik P; Carrat F; Nion-Larmurier I; Vienne A; Beaugerie L; Cosnes J
Gut; 2010 Oct; 59(10):1363-8. PubMed ID: 20587545
[TBL] [Abstract][Full Text] [Related]
13. An update on biosimilar drugs for inflammatory bowel disease.
Schreiber S
Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():1-3. PubMed ID: 26395529
[TBL] [Abstract][Full Text] [Related]
14. Table: safety of drugs for IBD in pregnancy.
Med Lett Drugs Ther; 2018 Jul; 60(1550):e116. PubMed ID: 30036355
[No Abstract] [Full Text] [Related]
15. [Perspectives in inflammatory bowel diseases treatment].
Jalocha L; Wojtuń S; Dyrla P; Błaszak A; Wojtkowiak M; Zyśko B; Stelmaszuk T; Gil J
Pol Merkur Lekarski; 2009 May; 26(155):556-8. PubMed ID: 19606725
[TBL] [Abstract][Full Text] [Related]
16. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Ochsenkühn T; Sackmann M; Göke B
Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of inflammatory bowel diseases.
Van Assche G; Vermeire S; Rutgeerts P
Curr Opin Gastroenterol; 2005 Jul; 21(4):443-7. PubMed ID: 15930985
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of chronic inflammatory bowel diseases].
Stange EF
Praxis (Bern 1994); 2002 Nov; 91(47):2029-39. PubMed ID: 12501498
[TBL] [Abstract][Full Text] [Related]
19. Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.
Panaccione R; Rutgeerts P; Sandborn WJ; Feagan B; Schreiber S; Ghosh S
Aliment Pharmacol Ther; 2008 Sep; 28(6):674-88. PubMed ID: 18532990
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease: short- and long-term treatments.
Bickston SJ; Cominelli F
Adv Intern Med; 1998; 43():143-74. PubMed ID: 9506181
[No Abstract] [Full Text] [Related]
[Next] [New Search]